Acer Medical, part of the Acer Group and a specialist in medical imaging and AI-powered healthcare solutions, announced aiMed, its new generative AI medical documentation system. The announcement took place at the next@acer global press conference ahead of IFA 2025 in Berlin. This launch highlights Acer Medical’s expanding global presence and its goal of transforming healthcare through AI and digital innovation.
Tackling Documentation Overload in Healthcare
One of the most pressing challenges in modern healthcare is clinical documentation overload. Studies show that healthcare providers spend up to 25 percent of their working hours on medical record keeping. This reduces the time available for patient care and contributes to professional burnout.
aiMed directly addresses this issue by applying real-time AI processing designed specifically for healthcare environments. It transforms voice dictation or typed notes into structured electronic medical records (EMRs). The system ensures accuracy, completeness, and compliance with medical documentation standards, while also streamlining clinical workflows.
Key Benefits of aiMed
By automating documentation, aiMed improves efficiency and reduces strain on healthcare professionals. The system offers several benefits:
- Reduces administrative workload for healthcare providers
- Minimizes documentation errors in medical records
- Maintains interoperability with hospital information systems and EMR platforms
- Enhances patient safety and care quality by allowing more time for physician-patient interaction
aiMed includes an Automatic Speech Recognition (ASR) function that is purpose-built for healthcare. It integrates specialized medical terminology and contextual understanding to improve accuracy. The platform also operates on a secure cloud-based architecture, ensuring data protection and privacy for sensitive medical information.
Building on the VeriSee Platform
Alongside aiMed, Acer Medical also offers the VeriSee platform, an AI-assisted ophthalmology analysis solution. VeriSee supports the integration of multiple AI modules, giving doctors the ability to select tools according to their clinical needs. Current modules include:
- VeriSee DR for Diabetic Retinopathy
- VeriSee AMD for Age-related Macular Degeneration
- VeriSee GLC for Glaucoma Suspect
The platform analyzes color retinal images and generates results within seconds. This rapid analysis helps hospitals and clinics deliver timely interventions for high-risk patients and supports improved preventive care.
VeriSee is now deployed in more than 500 clinics and hospitals across 14 international markets. Its adoption reflects growing demand for AI-assisted solutions that improve diagnostic efficiency and patient outcomes.
Advancing Digital Healthcare Innovation
Acer Medical’s introduction of aiMed marks a new step in the company’s mission to combine generative AI and diagnostic tools to support the healthcare sector. The company remains committed to creating solutions that enhance efficiency, reduce professional burden, and improve outcomes for patients.
By pairing medical documentation automation with AI-powered screening tools, Acer Medical aims to reshape digital healthcare. Its goal is to accelerate the global adoption of smart, secure, and sustainable medical solutions that meet the needs of providers and patients.
